OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism
Chiara Sanguinetti, Marianna Minniti, Vanessa Susini, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1906-1906
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Sex differences in transthyretin cardiac amyloidosis
Alberto Aimo, Giorgia Panichella, Manuel Garofalo, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 2, pp. 321-330
Open Access | Times Cited: 20

Amyloid-β-interacting proteins in peripheral fluids of Alzheimer’s disease
Yelim Yi, Jimin Lee, Mi Hee Lim
Trends in Chemistry (2024) Vol. 6, Iss. 3, pp. 128-143
Closed Access | Times Cited: 6

Hereditary Transthyretin Amyloidosis
Laura Obici, Giorgia Panichella, Roberta Mussinelli
(2024), pp. 53-67
Closed Access | Times Cited: 6

Hereditary cardiac amyloidosis associated with a rare p.Ala101Val transthyretin mutation: a case description
Shanshan Yuan, Miao Zhang, Wei Liu, et al.
Quantitative Imaging in Medicine and Surgery (2025) Vol. 15, Iss. 3, pp. 2625-2631
Open Access

Sub-3 Å Resolution Protein Structure Determination by Single-Particle Cryo-EM at 100 keV
Dimple Karia, Fujiet Koh, Wen Yang, et al.
(2025)
Closed Access

Hepatic Satellite Cell Activation and Alteration of Vitamin A Status Are Relevant to the Aggravation of Retinopathy by T2DM
Min-Chun Chang, David Pei‐Cheng Lin, Han‐Hsin Chang
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 2, pp. 7-7
Open Access

Hereditary Transthyretin Amyloidosis (ATTRv)
Filippos Triposkiadis, Αlexandros Briasoulis, Randall C. Starling, et al.
Current Problems in Cardiology (2025), pp. 103019-103019
Closed Access

Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis
Jaskeerat Gulati, Rose Pedretti, Nicholas Hendren, et al.
Current Heart Failure Reports (2025) Vol. 22, Iss. 1
Closed Access

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer’s disease
Swetaleena Shaw, Pratyush Porel, Khadga Raj Aran
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Rna-Targeting Therapies For Amyloid Transthyretin Cardiomyopathy: A Systematic Review And Meta-Analysis
João Victor de Oliveira Ramos, João Vítor Andrade Fernandes, Yan Gadelha de Abrantes Formiga, et al.
Current Problems in Cardiology (2025), pp. 103057-103057
Closed Access

Antisense Oligonucleotides: A Promising Advancement in Neurodegenerative Disease Treatment
Katarzyna Dudzisz, Ilona Wandzik
European Journal of Pharmacology (2025), pp. 177644-177644
Closed Access

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
Paolo Morfino, Alberto Aimo, Giuseppe Vergaro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1129-1129
Open Access | Times Cited: 10

Role of Saturation and Length of Fatty Acids of Phosphatidylserine in the Aggregation of Transthyretin
Abid Ali, Kiryl Zhaliazka, Tianyi Dou, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3499-3506
Open Access | Times Cited: 10

Optimization Of The Search For Neuroprotectors Among Bioflavonoids
И. Ф. Беленичев, Victor Ryzhenko, Olena Popazova, et al.
(2024)
Open Access | Times Cited: 3

Recent Advances in Positron Emission Tomography Radiotracers to Image Cardiac Amyloidosis
Ardel J. Romero Pabón, Olivier Clerc, S. Vijayakumar, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 11, pp. 1153-1162
Closed Access | Times Cited: 3

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments
David Adams, Vincent Algalarrondo, Andoni Echaniz‐Laguna
Blood (2023) Vol. 142, Iss. 19, pp. 1600-1612
Closed Access | Times Cited: 7

Clinical Use of Biomarkers in Cardiac Amyloidosis
Andrea Lalario, Riccardo Saro, Gianfranco Sinagra, et al.
Heart Failure Clinics (2024) Vol. 20, Iss. 3, pp. 283-294
Closed Access | Times Cited: 2

Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease
Camilla Corino, Alberto Aimo, Marco Luigetti, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 2

Exploring Transthyretin Amyloid Cardiomyopathy: A Comprehensive Review of the Disease and Upcoming Treatments
Hritvik Jain, Murali Mohan Rama Krishna Reddy, Rohit Chandra Dey, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102057-102057
Closed Access | Times Cited: 6

Cholesterol and Sphingomyelin Uniquely Alter the Rate of Transthyretin Aggregation and Decrease the Toxicity of Amyloid Fibrils
Abid Ali, Kiryl Zhaliazka, Tianyi Dou, et al.
The Journal of Physical Chemistry Letters (2023) Vol. 14, Iss. 49, pp. 10886-10893
Open Access | Times Cited: 6

Plasmalogens Alter the Aggregation Rate of Transthyretin and Lower Toxicity of Transthyretin Fibrils
Jadon Sitton, Abid Ali, Luke Osborne, et al.
The Journal of Physical Chemistry Letters (2024) Vol. 15, Iss. 17, pp. 4761-4766
Open Access | Times Cited: 2

Nanoscale structural characterization of transthyretin aggregates formed at different time points of protein aggregation using atomic force microscopy‐infrared spectroscopy
Axell Rodriguez, Abid Ali, Aidan P. Holman, et al.
Protein Science (2023) Vol. 32, Iss. 12
Closed Access | Times Cited: 4

Optimization of the Search for Neuroprotectors among Bioflavonoids
И. Ф. Беленичев, Victor Ryzhenko, Olena Popazova, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 877-877
Open Access | Times Cited: 1

Examining the Difficulties in Identifying and Handling Cardiac Amyloidosis; Acquiring Important Knowledge and Robust Treatment Methods
Ghadir Mohammed Saleh Ali, William Ale Emmanuel Seme, Kiran Dudhat
Cardiovascular & Haematological Disorders - Drug Targets (2024) Vol. 24, Iss. 2, pp. 65-82
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top